Alessi JV, Elkrief A, Ricciuti B, Wang X, et al. Clinicopathologic and genomic factors impacting efficacy of first-line chemoimmunotherapy in advanced non-small cell lung cancer (NSCLC). J Thorac Oncol 2023 Feb 10:S1556-0864(23)00121.
PMID: 36775193